Trial intelligence / Profile preview

Hypertonic glucose infusion in non-diabetic hemodialysis patients

IRCT20121229011923N8Phase 3Completed

Sponsor
Shoushtar Faculty of Medical Sciences
Start
Feb 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of glucose in end-stage kidney disease (ESKD), sponsored by Shoushtar Faculty of Medical Sciences. Started Feb 2020; status: completed.

02

Drugs

glucose
03

Conditions

end-stage kidney disease (ESKD)

Beyond the preview

Go deeper on IRCT20121229011923N8.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20121229011923N8.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call